Biochemical and Biophysical Research Communications · 2017 · 35 citations · 22 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyTranscriptional RegulationCancer ProgressionCancer Stem Cell BiologyCancer Stem Cell MaintenanceCancer Stem CellsLung CancerLung MetastasisCancer Stem-like CellsMetastatic Cancer Stem CellsNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentStemness RegulationTherapeutic Target IdentificationTranscriptional ActivationTumor Initiating Cells
population. Conversely, reduced YBX1 impaired CSC properties of NSCLC cells in vitro and tumor-initiating frequencies, as well as metastasis in vivo. Importantly, we described a mechanism whereby YBX1 directly promoted NANOG, a transcription factor, transcriptional activation. Depletion of NANOG abolished the enhanced ability of invasion and sphere formation in YBX1 elevated-A549 cells. Collectively, these findings demonstrate a novel role of YBX1 in maintaining the stemness of CSCs and metastasis, unveiling YBX1 as promising therapeutic target for NSCLC treatments.
22
Claudia Allemani, Hannah K. Weir, Helena Carreira et al. · The Lancet · 2014 · 2.7K citations · Full text
Medicine, Biostatistics, Oncology +17
Wen Cai Zhang, Ng Shyh‐Chang, Yang He et al. · Cell · 2012 · 673 citations · Full text
Shih‐Hwa Chiou, Mong‐Lien Wang, Yu‐Ting Chou et al. · Cancer Research · 2010 · 576 citations · Full text